CLOs on the Move

Noom

www.noom.com

 
Noom is the world`s leading behavior change company, disrupting the weight loss and healthcare industries. By combining the power of artificial intelligence, mobile tech, and psychology with the empathy of over 1,000 personal coaches, Noom helps people live healthier lives by changing their long-term habits. More than 50 million people have benefited from Noom`s behavior change courses, including its virtual diabetes prevention program, which was the first of its kind to be recognized by the CDC. The Noom platform is already being used by leading healthcare and pharmaceutical companies to improve treatment outcomes for patients worldwide. The company is headquartered ...
  • Number of Employees: 1K-5K
  • Annual Revenue: > $1 Billion
  • www.noom.com
  • 229 West 28th Street Floor 9
    New York, NY USA 10001
  • Phone: 800.910.7375

Executives

Name Title Contact Details
James Zhou
 Chief Information Security Officer and Senior Director, Systems Operations Profile
Eric Cheng
 Associate General Counsel Profile
Norman Petty
 General Counsel Profile
Michal Rosenn
 General Counsel Profile
Michal Rosenn
 General Counsel Profile

Similar Companies

Familymeds Group Inc

Familymeds Group Inc is a Farmington, CT-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Mahaska Health Partnership

Mahaska Health Partnership is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in Oskaloosa, IA. To find more information about Mahaska Health Partnership, please visit www.mahaskahealth.org

Baldwin Emergency Medical Service

Baldwin Emergency Medical Service is a Pittsburgh, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

AVANZA Laboratories

AVANZA Laboratories is a Gaithersburg, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Bionor Pharma

Bionor Pharma is a leading biotechnology company advancing the first therapeutic vaccine towards a functional cure for HIV. The company`s focus is the research and development of peptide-based vaccines against viral diseases, primarily HIV. Bionor Pharma`s most advanced product candidate is Vacc-4x, which is also the most advanced therapeutic vaccine in the HIV space and has demonstrated a reduction of viral load in a large, randomized, controlled Phase II trial, as well as safety and tolerability. Pharma`s current clinical focus is to explore whether Vacc-4x, used with other medicines as a combination therapy, can reduce the viral load even further, and the company, through collaboration with Celgene, is investigating Vacc-4x and the HDAC inhibitor romidepsin in the REDUC study. In May 2015, Bionor Pharma announced promising results from an interim analysis of Part B of the REDUC study. In the study, Vacc-4x and romidepsin are explored as a possible treatment regimen to reduce the persistent latent viral reservoir in HIV infected patients on anti-retroviral treatment. Results are expected in the second half of 2015. Bionor Pharma is headquartered in Oslo, Norway, with offices in Copenhagen and New York.